Patients' perceptions and experiences of taking oral glucose-lowering agents: a longitudinal qualitative study

Julia Lawton, Elizabeth Peel, Odette Parry, Margaret Douglas

Research output: Contribution to journalArticle

Abstract

Aims The aims of this study were to examine Type 2 diabetic patients' expectations, perceptions and experiences of oral glucose-lowering agents (OGLAs), including their reasons for taking/not taking these drugs as prescribed and to provide recommendations for developing interventions to improve OGLA adherence. Methods Longitudinal, qualitative study using repeat in-depth interviews with patients (n = 20) over 4 years following clinical diagnosis. Respondents were recruited from primary and secondary care settings across Lothian, Scotland, UK. Results Despite experiences of side-effects, dislikes and concerns about taking multiple drugs and a belief that OGLAs could themselves cause one's diabetes to progress, most respondents appeared motivated to take these drugs as prescribed. This motivation seemed to arise from respondents' experiences of taking OGLAs and observing them to 'work'. Some respondents described feeling better after taking OGLAs, others, typically those who were asymptomatic, used blood glucose self-monitoring and/or glycated haemoglobin results to observe and evidence the effects of their OGLAs. Most respondents demonstrated a 'passive' expectation that health professionals should be responsible for decisions about medications. Hence, non-adherence typically resulted from forgetfulness rather than ambivalence about either medication or consultation style. Respondent concern about OGLA's largely centred upon lack of knowledge about the medication and what to do when doses were missed. Conclusion The findings call for multifaceted strategies to promote adherence. These could include education to address misconceptions and advise patients how to respond to missed doses; reminders to help patients remember to take their drugs; and structured feedback on the impact of OGLAs on glycaemic control.
Original languageEnglish
Pages (from-to)491-495
Number of pages5
JournalDiabetic Medicine
Volume25
Issue number4
DOIs
Publication statusPublished - Apr 2008

Fingerprint

Longitudinal Studies
Glucose
Pharmaceutical Preparations
Blood Glucose Self-Monitoring
Secondary Care
Glycosylated Hemoglobin A
Scotland
Surveys and Questionnaires
Motivation
Primary Health Care
Emotions
Referral and Consultation
Interviews
Education
Health

Keywords

  • adherence
  • interventions
  • oral glucose-lowering agents
  • patients' perspectives
  • qualitative

Cite this

Lawton, Julia ; Peel, Elizabeth ; Parry, Odette ; Douglas, Margaret. / Patients' perceptions and experiences of taking oral glucose-lowering agents: a longitudinal qualitative study. In: Diabetic Medicine. 2008 ; Vol. 25, No. 4. pp. 491-495.
@article{3818f725e2c24eb58e5b01759f2b58ba,
title = "Patients' perceptions and experiences of taking oral glucose-lowering agents: a longitudinal qualitative study",
abstract = "Aims The aims of this study were to examine Type 2 diabetic patients' expectations, perceptions and experiences of oral glucose-lowering agents (OGLAs), including their reasons for taking/not taking these drugs as prescribed and to provide recommendations for developing interventions to improve OGLA adherence. Methods Longitudinal, qualitative study using repeat in-depth interviews with patients (n = 20) over 4 years following clinical diagnosis. Respondents were recruited from primary and secondary care settings across Lothian, Scotland, UK. Results Despite experiences of side-effects, dislikes and concerns about taking multiple drugs and a belief that OGLAs could themselves cause one's diabetes to progress, most respondents appeared motivated to take these drugs as prescribed. This motivation seemed to arise from respondents' experiences of taking OGLAs and observing them to 'work'. Some respondents described feeling better after taking OGLAs, others, typically those who were asymptomatic, used blood glucose self-monitoring and/or glycated haemoglobin results to observe and evidence the effects of their OGLAs. Most respondents demonstrated a 'passive' expectation that health professionals should be responsible for decisions about medications. Hence, non-adherence typically resulted from forgetfulness rather than ambivalence about either medication or consultation style. Respondent concern about OGLA's largely centred upon lack of knowledge about the medication and what to do when doses were missed. Conclusion The findings call for multifaceted strategies to promote adherence. These could include education to address misconceptions and advise patients how to respond to missed doses; reminders to help patients remember to take their drugs; and structured feedback on the impact of OGLAs on glycaemic control.",
keywords = "adherence, interventions, oral glucose-lowering agents, patients' perspectives, qualitative",
author = "Julia Lawton and Elizabeth Peel and Odette Parry and Margaret Douglas",
year = "2008",
month = "4",
doi = "10.1111/j.1464-5491.2008.02400.x",
language = "English",
volume = "25",
pages = "491--495",
journal = "Diabetic Medicine",
issn = "0742-3071",
publisher = "Wiley-Blackwell",
number = "4",

}

Patients' perceptions and experiences of taking oral glucose-lowering agents: a longitudinal qualitative study. / Lawton, Julia; Peel, Elizabeth; Parry, Odette; Douglas, Margaret.

In: Diabetic Medicine, Vol. 25, No. 4, 04.2008, p. 491-495.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Patients' perceptions and experiences of taking oral glucose-lowering agents: a longitudinal qualitative study

AU - Lawton, Julia

AU - Peel, Elizabeth

AU - Parry, Odette

AU - Douglas, Margaret

PY - 2008/4

Y1 - 2008/4

N2 - Aims The aims of this study were to examine Type 2 diabetic patients' expectations, perceptions and experiences of oral glucose-lowering agents (OGLAs), including their reasons for taking/not taking these drugs as prescribed and to provide recommendations for developing interventions to improve OGLA adherence. Methods Longitudinal, qualitative study using repeat in-depth interviews with patients (n = 20) over 4 years following clinical diagnosis. Respondents were recruited from primary and secondary care settings across Lothian, Scotland, UK. Results Despite experiences of side-effects, dislikes and concerns about taking multiple drugs and a belief that OGLAs could themselves cause one's diabetes to progress, most respondents appeared motivated to take these drugs as prescribed. This motivation seemed to arise from respondents' experiences of taking OGLAs and observing them to 'work'. Some respondents described feeling better after taking OGLAs, others, typically those who were asymptomatic, used blood glucose self-monitoring and/or glycated haemoglobin results to observe and evidence the effects of their OGLAs. Most respondents demonstrated a 'passive' expectation that health professionals should be responsible for decisions about medications. Hence, non-adherence typically resulted from forgetfulness rather than ambivalence about either medication or consultation style. Respondent concern about OGLA's largely centred upon lack of knowledge about the medication and what to do when doses were missed. Conclusion The findings call for multifaceted strategies to promote adherence. These could include education to address misconceptions and advise patients how to respond to missed doses; reminders to help patients remember to take their drugs; and structured feedback on the impact of OGLAs on glycaemic control.

AB - Aims The aims of this study were to examine Type 2 diabetic patients' expectations, perceptions and experiences of oral glucose-lowering agents (OGLAs), including their reasons for taking/not taking these drugs as prescribed and to provide recommendations for developing interventions to improve OGLA adherence. Methods Longitudinal, qualitative study using repeat in-depth interviews with patients (n = 20) over 4 years following clinical diagnosis. Respondents were recruited from primary and secondary care settings across Lothian, Scotland, UK. Results Despite experiences of side-effects, dislikes and concerns about taking multiple drugs and a belief that OGLAs could themselves cause one's diabetes to progress, most respondents appeared motivated to take these drugs as prescribed. This motivation seemed to arise from respondents' experiences of taking OGLAs and observing them to 'work'. Some respondents described feeling better after taking OGLAs, others, typically those who were asymptomatic, used blood glucose self-monitoring and/or glycated haemoglobin results to observe and evidence the effects of their OGLAs. Most respondents demonstrated a 'passive' expectation that health professionals should be responsible for decisions about medications. Hence, non-adherence typically resulted from forgetfulness rather than ambivalence about either medication or consultation style. Respondent concern about OGLA's largely centred upon lack of knowledge about the medication and what to do when doses were missed. Conclusion The findings call for multifaceted strategies to promote adherence. These could include education to address misconceptions and advise patients how to respond to missed doses; reminders to help patients remember to take their drugs; and structured feedback on the impact of OGLAs on glycaemic control.

KW - adherence

KW - interventions

KW - oral glucose-lowering agents

KW - patients' perspectives

KW - qualitative

UR - http://www.scopus.com/inward/record.url?scp=41749115478&partnerID=8YFLogxK

UR - http://www3.interscience.wiley.com/journal/119405141/abstract

U2 - 10.1111/j.1464-5491.2008.02400.x

DO - 10.1111/j.1464-5491.2008.02400.x

M3 - Article

VL - 25

SP - 491

EP - 495

JO - Diabetic Medicine

JF - Diabetic Medicine

SN - 0742-3071

IS - 4

ER -